Related Topics News -

     
 Title only   |   Print    Next page > 
     
兆科眼科料下半年多個產品申請陸續獲批 冀今年將國際網絡拓展至拉美或南美洲

2026-04-01T  
《業績》兆科眼科全年虧損收窄至2.09億人民幣

2026-03-25T  
兆科眼科滴眼液BRIMOCHOL PF獲美FDA批准商業化

2026-01-30T  
兆科眼科授出BRIMOCHOL PF新加坡及越南獨家分銷權

2026-01-26T  
兆科眼科滴眼液NVK002註冊申請獲澳洲治療用品局受理

2026-01-13T  
兆科眼科就於台灣商業化BRIMOCHOL PF與東生華製藥訂立策略性夥伴關係

2025-12-08T  
兆科眼科兩滴眼液分別獲批新藥臨床試驗申請及上市

2025-11-24T  
兆科眼科與印尼藥企PT Ferron就分銷老花眼藥達成協議

2025-11-06T  
兆科眼科合作夥伴已向韓國食品藥品安全部提交BRIMOCHOL PF新藥申請

2025-11-05T  
兆科眼科三款產品料明年次季至第三季內地獲批 今年虧損或收窄

2025-09-01T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.